Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Dexcom (DXCM) Receivables - Net (2016 - 2025)

Dexcom (DXCM) has disclosed Receivables - Net for 16 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 21.06% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 21.06% increase, with the full-year FY2025 number at $1.2 billion, up 21.06% from a year prior.
  • Receivables - Net was $1.2 billion for Q4 2025 at Dexcom, up from $1.1 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.3 billion in Q2 2025 to a low of $443.4 million in Q1 2021.
  • A 5-year average of $814.1 million and a median of $768.2 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 63.07% in 2021, then grew 4.21% in 2024.
  • Dexcom's Receivables - Net stood at $514.3 million in 2021, then surged by 38.69% to $713.3 million in 2022, then soared by 36.53% to $973.9 million in 2023, then increased by 4.21% to $1.0 billion in 2024, then increased by 21.06% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Receivables - Net are $1.2 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.3 billion (Q2 2025).